Conservation analysis of dengue virust-cell epitope-based vaccine candidates using peptide block entropy

Frontiers in Immunology

Volumn 2, Issue DEC, 2011, Pages

  Olsen, Lars Rønn ^a,b   Zhang, Guang Lan ^a   Keskin, Derin B ^a,c   Reinherz, Ellis L ^a,c   Brusic, Vladimir ^a,c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Antigenic diversity; Epitope based vaccines; Immunoinformatics; Polyvalent vaccines; Reverse vaccinol ogy; Vaccine informatics

Indexed keywords

EID: 84867636845     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2011.00069     Document Type: Article

References (50)

1. Appay, V. (2009). 25 years of HIV research!...and what about a vaccine? Eur. J. Immunol. 39, 1999-2003.
2. Barouch, D. H., O'brien, K. L., Simmons, N. L., King, S. L., Abbink, P., Maxfield, L. F., Sun, Y. H., La Porte, A., Riggs, A. M., Lynch, D. M., Clark, S. L., Backus, K., Perry, J. R., Seaman, M. S., Carville, A., Mansfield, K. G., Szinger, J. J., Fischer, W., Muldoon, M., and Korber, B. (2010). Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys. Nat. Med. 16, 319-323.
3. Benson, D. A., Karsch-Mizrachi, I., Lipman, D. J., Ostell, J., and Sayers, E. W. (2010). GenBank. Nucleic Acids Res. 38, D46-D51.
4. Brown, J. H., Jardetzky, T. S., Gorga,J. C., Stern, L. J., Urban, R. G., Strominger, J. L., and Wiley, D. C. (1993). Threedimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364, 33-39.
5. Brown, L. E., and Kelso, A. (2009). Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes. Immunol. Cell Biol. 87, 300-308.
6. Brusic, V., and August, J. T. (2004). The changing field of vaccine development in the genomics era. Pharmacogenomics 5, 597-600.
7. Crooks, G. E., Hon, G., Chandonia, J. M., and Brenner, S. E. (2004). WebLogo: a sequence logo generator. Genome Res. 14, 1188-1190.
8. De Groot, A. S., Marcon, L., Bishop, E. A., Rivera, D., Kutzler, M., Weiner, D. B., and Martin, W. (2005). HIV vaccine development by computer assisted design: the GAIA vaccine. Vaccine 23, 2136-2148.
9. De Groot, A. S., and Rappuoli, R. (2004). Genome-derived vaccines. Expert Rev. Vaccines 3, 59-76.
10. Duangchinda, T., Dejnirattisai, W., Vasanawathana, S., Limpitikul, W., Tangthawornchaikul, N., Malasit, P., Mongkolsapaya, J., and Screaton, G. (2010). Immunodominant T-cell responses to dengue virus NS3 are associated with DHF. Proc. Natl. Acad. Sci. U.S.A. 107, 16922-16927.
11. Falk, K., Rotzschke, O., Stevanovic, S., Jung, G., and Rammensee, H. G. (1991). Allele-specific motifs revealed by sequencing of selfpeptides eluted from MHC molecules. Nature 351, 290-296.
12. Fischer, W., Perkins, S., Theiler, J., Bhattacharya, T., Yusim, K., Funkhouser, R., Kuiken, C., Haynes, B., Letvin, N. L., Walker, B. D., Hahn, B. H., and Korber, B. T. (2007). Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants. Nat. Med. 13, 100-106.
13. Franco, C., Hynes, N. A., Bouri, N., and Henderson, D. A. (2010). The dengue threat to the United States. Biosecur. Bioterror. 8, 273-276.
14. Gao, F., Weaver, E. A., Lu, Z., Li, Y., Liao, H. X., Ma, B., Alam, S. M., Scearce, R. M., Sutherland, L. L., Yu, J. S., Decker, J. M., Shaw, G. M., Montefiori, D. C., Korber, B. T., Hahn, B. H., and Haynes, B. F. (2005). Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type 1 group m consensus envelope glycoprotein. J. Virol. 79, 1154-1163.
15. Gaschen, B., Taylor, J., Yusim, K., Foley, B., Gao, F., Lang, D., Novitsky, V., Haynes, B., Hahn, B. H., Bhattacharya, T., and Korber, B. (2002). Diversity considerations in HIV-1 vaccine selection. Science 296, 2354-2360.
16. Guy, B., Saville, M., and Lang, J. (2010). Development of Sanofi Pasteur tetravalent dengue vaccine. Hum. Vaccin. 6, 696-705.
17. Halstead, S. B., and O'rourke, E. J. (1977). Dengue viruses and mononuclear phagocytes. I. Infection enhancement by nonneutralizing antibody. J. Exp. Med. 146, 201-217.
18. Halstead, S. B., O'rourke, E. J., and Allison, A. C. (1977). Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in vitro infection. J. Exp. Med. 146, 218-229.
19. Hertz, T., Nolan, D., James, I., John, M., Gaudieri, S., Phillips, E., Huang, J. C., Riadi, G., Mallal, S., and Jojic, N. (2011). Mapping the landscape of host-pathogen coevolution: HLA class I binding and its relationship with evolutionary conservation in human and viral proteins. J. Virol. 85, 1310-1321.
20. Hu, D. J., Dondero, T. J., Rayfield, M. A., George, J. R., Schochetman, G., Jaffe, H. W., Luo, C. C., Kalish, M. L., Weniger, B. G., Pau, C. P., Schable, C. A., and Curran, J. W. (1996). The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research, and prevention. JAMA 275, 210-216.
21. Katoh, K., and Toh, H. (2008). Recent developments in the MAFFT multiple sequence alignment program. Brief. Bioinformatics 9, 286-298.
22. Khan, A. M., Miotto, O., Nascimento, E. J., Srinivasan, K. N., Heiny, A. T., Zhang, G. L., Marques, E. T., Tan, T. W., Brusic, V., Salmon, J., and August, J. T. (2008). Conservation and variability of dengue virus proteins: implications for vaccine design. PLoS Negl. Trop. Dis. 2, e272. doi:10.1371/journal.pntd.0000272
23. Koo, Q. Y., Khan, A. M., Jung, K. O., Ramdas, S., Miotto, O., Tan, T. W., Brusic, V., Salmon, J., and August, J. T. (2009). Conservation and variability of West Nile virus proteins. PLoS ONE 4, e5352. doi:10.1371/journal.pone.0005352
24. Lin, H. H., Ray, S., Tongchusak, S., Reinherz, E. L., and Brusic, V. (2008). Evaluation of MHC class I peptide binding prediction servers: applications for vaccine research. BMC Immunol. 9, 8. doi:10.1186/1471-2172-9-8
25. Lio, P., Politi, A., Buiatti, M., and Ruffo, S. (1996). High statistics block entropy measures of DNA sequences. J. Theor. Biol. 180, 151-160.
26. Lundegaard, C., Lamberth, K., Harndahl, M., Buus, S., Lund, O., and Nielsen, M. (2008). NetMHC-3.0: accurate web accessible predictions of human,mouse and monkey MHC class I affinities for peptides of length 8-11. Nucleic Acids Res. 36, W509- W512.
27. Mackenzie, J. S., Gubler, D. J., and Petersen, L. R. (2004). Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat. Med. 10, S98-S109.
28. Martinez, A. N., Tenzer, S., and Schild, H. (2009). T-cell epitope processing (the epitope flanking regions matter). Methods Mol. Biol. 524, 407-415.
29. Morrison, D., Legg, T. J., Billings, C. W., Forrat, R., Yoksan, S., and Lang, J. (2010). A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in Flavivirus-naive adults. J. Infect. Dis. 201, 370-377.
30. Murrell, S., Wu, S. C., and Butler, M. (2011). Review of dengue virus and the development of a vaccine. Biotechnol. Adv. 29, 239-247.
31. Nickle, D. C., Rolland, M., Jensen, M. A., Pond, S. L., Deng, W., Seligman, M., Heckerman, D., Mullins, J. I., and Jojic, N. (2007). Coping with viral diversity in HIV vaccine design. PLoS Comput. Biol. 3, e75. doi:10.1371/journal.pcbi.0030075
32. Nikolich-Zugich, J., Slifka, M. K., and Messaoudi, I. (2004). The many important facets of T-cell repertoire diversity. Nat. Rev. Immunol. 4, 123-132.
33. Olsen, L. R., Zhang, G. L., Reinherz, E. L., and Brusic, V. (2011). FLAVIdB: a data mining system for knowledge discovery in flaviviruses with direct applications in immunology and vaccinology. Immunome Res. 8, 1.
34. Pilla, L., Rivoltini, L., Patuzzo, R., Marrari, A., Valdagni, R., and Parmiani, G. (2009). Multipeptide vaccination in cancer patients. Expert Opin. Biol. Ther. 9, 1043-1055.
35. Purcell, A. W., Mccluskey, J., and Rossjohn, J. (2007). More than one reason to rethink the use of peptides in vaccine design. Nat. Rev. Drug Discov. 6, 404-414.
36. Rammensee, H., Bachmann, J., Emmerich, N. P., Bachor, O. A., and Stevanovic, S. (1999). SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50, 213-219.
37. Rappuoli, R. (2000). Reverse vaccinology. Curr. Opin. Microbiol. 3, 445-450.
38. Reche, P. A., Keskin, D. B., Hussey, R. E., Ancuta, P., Gabuzda, D., and Reinherz, E. L. (2006). Elicitation from virus-naive individuals of cytotoxic T lymphocytes directed against conserved HIV-1 epitopes. Med. Immunol. 5, 1.
39. Reinhold, B., Keskin, D. B., and Reinherz, E. L. (2010). Molecular detection of targeted major histocompatibility complex I-bound peptides using a probabilistic measure and nanospray MS(3) on a hybrid quadrupolelinear ion trap. Anal. Chem. 82, 9090-9099.
40. Riemer, A. B., Keskin, D. B., Zhang, G., Handley, M., Anderson, K. S., Brusic, V., Reinhold, B., and Reinherz, E. L. (2010). A conserved E7derived cytotoxic T lymphocyte epitope expressed on human papillomavirus 16-transformed HLA-A2+ epithelial cancers. J. Biol. Chem. 285, 29608-29622.
41. Rolland, M., Frahm, N., Nickle, D. C., Jojic, N., Deng, W., Allen, T. M., Brander, C., Heckerman, D. E., and Mullins, J. I. (2011). Increased breadth and depth of cytotoxic T lymphocytes responses against HIV-1-B Nef by inclusion of epitope variant sequences. PLoS ONE 6, e17969. doi:10.1371/journal.pone. 0017969
42. Santra, S., Liao, H. X., Zhang, R., Muldoon, M., Watson, S., Fischer, W., Theiler, J., Szinger, J., Balachandran, H., Buzby, A., Quinn, D., Parks, R. J., Tsao, C. Y., Carville, A., Mansfield, K. G., Pavlakis, G. N., Felber, B. K., Haynes, B. F., Korber, B. T., and Letvin, N. L. (2010). Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys. Nat. Med. 16, 324-328.
43. Schneider, T. D., and Stephens, R. M. (1990). Sequence logos: a new way to display consensus sequences. Nucleic Acids Res. 18, 6097-6100.
44. Sette, A., Grey, H., Oseroff, C., Peters, B., Moutaftsi, M., Crotty, S., Assarsson, E., Greenbaum, J., Kim, Y., Kolla, R., Tscharke, D., Koelle, D., Johnson, R. P., Blum, J., Head, S., and Sidney, J. (2009). Definition of epitopes and antigens recognized by vaccinia specific immune responses: their conservation in variola virus sequences, and use as a model system to study complex pathogens. Vaccine 27(Suppl. 6), G21-G26.
45. Sette, A., and Rappuoli, R. (2010). Reverse vaccinology: developing vaccines in the era of genomics. Immunity 33, 530-541.
46. Shannon, C. E. (1948). A mathematical theory of communication. Bell Syst. Tech. J. 27, 379-423; 623-656.
47. Tan, P. T., Heiny, A. T., Miotto, O., Salmon, J., Marques, E. T., Lemonnier, F., and August, J. T. (2010). Conservation and diversity of influenza A H1N1 HLA-restricted T cell epitope candidates for epitopebased vaccines. PLoS ONE 5, e8754. doi: 10.1371/journal.pone. 0008754
48. Vita, R., Zarebski, L., Greenbaum, J. A., Emami, H., Hoof, I., Salimi, N., Damle, R., Sette, A., and Peters, B. (2010). The immune epitope database 2.0. Nucleic Acids Res. 38, D854-D862.
49. Yerly, D., Heckerman, D., Allen, T., Suscovich, T. J., Jojic, N., Kadie, C., Pichler,W. J., Cerny,A., and Brander, C. (2008). Design, expression, and processing of epitomized hepatitis C virus-encoded CTL epitopes. J. Immunol. 181, 6361-6370.
50. Zhang, G. L., Deluca, D. S., Keskin, D. B., Chitkushev, L., Zlateva, T., Lund, O., Reinherz, E. L., and Brusic, V. (2011). MULTIPRED2: A computational system for large-scale identification of peptides predicted to bind to HLA supertypes and alleles. J. Immunol. Methods 374, 53-61.